FDA
approval
· 2006-05-26
FDA Approved: ORACEA — Original Application (Galderma Laboratories, L.P.)
Summary
The FDA approved ORACEA (doxycycline) under an original NDA for the treatment of inflammatory lesions of rosacea in adults. It uses a 40 mg sub-antimicrobial do…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ORACEA (DOXYCYCLINE)